Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals. Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals.” In accordance with this philosophy, as we implement our business activities we strive to realize our vision, which expresses that “Mitsubishi Tanabe Pharma strive to be a global research-driven pharmaceutical company that is trusted by communities.” As a company that is trusted and highly evaluated by patients and health care professionals as well as by society and shareholders, we will implement management with a focus on transparency and fairness while always keeping in mind the starting point of our business activities: “Everything we do is for the patients.”

ISTA Pharmaceuticals is a commercial-stage multispecialty pharmaceutical company. It discovers, develops, and markets remedies for diseases and conditions of the eye in the United States. The company offers products to treat allergies and serious diseases of the eye; and therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. The company’s marketed products comprise of BROMDAY, a bromfenac ophthalmic solution for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extractions; BEPREVE, a bepotastine besilate ophthalmic solution for ocular itching associated with allergic conjunctivitis; ISTALOL, a timolol maleate ophthalmic solution for the treatment of glaucoma; and VITRASE, a hyaluronidase injection for use as a spreading agent. Its products under development include OTC artificial tear products to treat dry eye and other ocular conditions; PROLENSA, a bromfenac ophthalmic solution for the treatment of postoperative inflammation and reduction of ocular pain after cataract extractions; T-PRED for steroid responsive inflammation; BEPOMAX and BEPOSONE nasal sprays for treating allergic rhinitis; and Bromfenac Adjunct for age-related macular degeneration. In addition, the company develops iganidipine to enhance ocular nerve blood flow; latanoprost, a prostaglandin for the treatment of glaucoma; and ecabet sodium for the treatment of dry eye. ISTA Pharmaceuticals sells its products to drug wholesalers; retailers and distributors such as chain drug stores, hospitals, clinics, and government agencies; and managed healthcare providers including health maintenance organizations and other institutions. ISTA Pharmaceuticals was founded in 1992 and is headquartered in Irvine, California. As of June 5, 2012, ISTA Pharmaceuticals operates as a subsidiary of Bausch & Lomb Incorporated.

Bausch & Lomb is a Canadian eye health products company based in Laval, Quebec, Canada. It is one of the world's largest suppliers of contact lenses, lens care products, pharmaceuticals, intraocular lenses, and other eye surgery products. The company was founded in Rochester, New York in 1853 by optician John Bausch and cabinet maker turned financial backer Henry Lomb. Until its sale in 2013, Bausch & Lomb was one of the oldest continually operating companies in the US.

Chongqing Huapont Pharmaceutical Co. Ltd., part of Huapont Life Sciences Co., Ltd., is a company headquartered in Chongqing, China. The firm manufactures pharmaceutical products.

Part of Bausch Health Cos., Inc., Bausch & Lomb Pharma Holdings Corp. is an American company that manufactures and markets pharmaceutical products.

Zhejiang Heze Pharmaceutical Technology Co., Ltd. engages in the research and development of medicine. It offers generic drug development, consistency evaluation of generic drugs, pharmaceutical research and innovative drug development, and clinical trial services. The company was founded on October 27, 2006 and is headquartered in Hangzhou, China.

Zhejiang Tianshun Pharmaceutical Co., Ltd., established on 2018-08-03, Business scope includes peptide products and intermediates,tablet,capsule,Granules,cataplasm,Production and sales of freeze-dried powder injections(The specific business scope shall be operated with a valid drug production license);Bioengineering technology development,Pharmaceutical Research Services,Technology development of pharmaceutical and chemical technology,technical consulting,technology transfer,Technical Services;Import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Jiangsu Lianhuan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and sale of chemicals and pharmaceutical products. It offers chemical synthetic drugs, antibiotics, and various preparations and auxiliary raw materials for medical use. The company was founded on February 22, 2000 and is headquartered in Yangzhou, China.

Bausch & Lomb Holdings, Inc. developed, manufactured, and sold eye health products. Its products included contact lenses, contact lens care solutions, ophthalmic pharmaceuticals, and surgical products. The company was founded on September 25, 2009 and was headquartered in Rochester, NY.

Nanjing Haina Pharmaceutical Co., Ltd., established on 2013-12-10, The business scope includes freeze-dried powder injection,tablet,dry suspension,Powder,Granules,gel,ointment,small volume injection(non-terminal sterilized)production and sales of;API R&D;Freeze-dried powder injection,small volume injection,tablet,hard capsule,Granules,Suspension,gel,cream,Development of ointment;Medical Technology Development,Research;Chemical product sales;Self-operated and agent import and export business of various commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nanjing Haina Pharmaceutical Technology Co., Ltd., established on 2001-04-09, Business scope includes pharmaceutical development,Research;Chemical product sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:pharmaceutical production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Beijing Xinlingxian Medical Technology Development Co., Ltd., part of Henan Taloph Pharmaceutical Stock Co., Ltd., is a Chinese company involved in commercial physical and biological research. Henan Taloph Pharmaceutical Stock Co., Ltd. acquired Beijing Xinlingxian Medical Technology Development Co., Ltd. on February 15, 2015 for $57.73 million.

Hefei Jiunuo Pharmaceutical Technology Co., Ltd., established on 2004-04-05, Business scope includes pharmaceutical products,Biological product,medical instruments,Development of cosmetics and health food,Technology Transfer and Service Consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Yichang Humanwell Pharmaceuticals Co., Ltd., part of Humanwell Healthcare (Group) Co., Ltd., is a Chinese company located in Yichang that develops and manufactures medicines and pharmaceutical products.

Shijiazhuang Green Pharmaceutical Co., Ltd., established on 2000-04-24, Business scope includes production,sales of chemical preparations,biochemical drug,API,Chemical Products(Dangerous goods and precursor chemicals are excluded),medical instruments,medical supplies,Disinfectant,Pharmaceutical packaging materials;API,Chemical Products(Dangerous goods and precursor chemicals are excluded),drug development,to develop;Realtor;Self-operated and agent import and export business of various commodities and technologies,Except for national restrictions and prohibitions(Production address:Qinling Street, High-tech Zone, Shijiazhuang588No).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Modern Pharmaceutical Preparation Engineering Research Center Co., Ltd., established on 1996-06-10, Business scope includes general items:Chinese and Western medicine preparations,Health care pharmaceutical preparations,Technology development on the application technology of pharmaceutical excipients,technical consulting,Technical Services,technology transfer;Design of preparation equipment,analyze;Pharmaceutical Raw Materials,Research on Testing Technology of Packaging Materials;Sales of preparation equipment;Own house rental.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Inspection and testing service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Nanjing Yinuo Pharmaceutical Technology Co., Ltd., established on 2018-06-05, Business scope includes medical technology development,Technical Services,technology transfer,technical consulting;Testing service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Chengdu Likai Chiral Tech Co. Ltd. (doing business as LKChiral) is a private company headquartered in Chengdu, China, that manufactures chiral reagents and chiral organic chemical intermediate products.

Nanjing Comer Biopharmaceutical Co., Ltd., established on 2020-06-18, Business scope includes licensed projects:Pharmaceutical commissioned production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Medical Research and Experimental Development;Biochemical product technology research and development;Development of Human Gene Diagnosis and Therapy Technology;Chemical product sales(No licensed chemical products);Conference and Exhibition Services;Information Consulting Service(Not including licensing information consulting services);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Zhongshan Yi Antai Pharmaceutical Technology Co., Ltd., established on 2007-02-13, Business scope includes production,Sales of pharmaceutical intermediates,Chemical materials(Free of Hazardous Chemicals);Research and development of pharmaceutical and chemical products and technical consulting services;Import and export,Technology transfer and import and export(law,Except for items prohibited by administrative regulations;law,Projects that are restricted by administrative regulations must obtain a license before they can operate).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)